Sirius Chemicals & Biologicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 6 Months
About Sirius Chemicals & Biologicals
Sirius Chemicals & Biologicals Private Limited (SCBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2023 (One year and six months 11 days old ). Its registered office is in Dindigul, Tamil Nadu, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nanthakumar Namasivayam and Shelton Clinton serve as directors at the Company.
Company Details
-
Location
Dindigul, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U23935TZ2023PTC029034
-
Company No.
029034
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jul 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Sirius Chemicals & Biologicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nanthakumar Namasivayam
|
Director | 28-Jul-2023 | Current |
|
Shelton Clinton
|
Director | 28-Jul-2023 | Current |
Financial Performance of Sirius Chemicals & Biologicals.
Enhance accessibility to Sirius Chemicals & Biologicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sirius Chemicals & Biologicals?
Unlock access to Sirius Chemicals & Biologicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
West Mount Chemicals LlpNanthakumar Namasivayam is a mutual person
-
Pawmine Animal Wellness Private Limited
Nanthakumar Namasivayam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sirius Chemicals & Biologicals?
Sirius Chemicals & Biologicals has a workforce of 0 employees as of Mar 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sirius Chemicals & Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirius Chemicals & Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.